Related Experiment Video
Updated: Jun 19, 2026

Quantification of Endothelial Fatty Acid Uptake using Fluorescent Fatty Acid Analogs
Published on: August 15, 2025
Trans-fatty acids and nonlipid risk factors
Sarah K Wallace1, Dariush Mozaffarian
1Department of Epidemiology, Harvard School of Public Health, Division of Cardiovascular Medicine and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Building 2-315, Boston, MA 02115, USA.
Industrially produced trans-fatty acids (TFA) increase coronary heart disease (CHD) risk beyond lipid effects. Emerging evidence links TFA to inflammation, insulin resistance, and other non-lipid factors contributing to heart disease and diabetes.
Area of Science:
- Nutrition Science
- Cardiovascular Disease Research
- Metabolic Health
Background:
- Industrial trans-fatty acids (TFA) are linked to coronary heart disease (CHD).
- Existing explanations focus on TFA's adverse effects on serum lipids.
- The full impact of TFA on health, including diabetes and sudden cardiac death, requires further investigation.
Purpose of the Study:
- To review evidence on the effects of trans-fatty acid intake on non-lipid risk factors for cardiovascular disease.
- To explore how these non-lipid effects contribute to the overall risk associated with TFA consumption.
Main Methods:
- Systematic review of evidence from randomized controlled trials.
- Analysis of observational studies, animal experiments, and in vitro studies.
- Evaluation of TFA effects on systemic inflammation, endothelial function, visceral adiposity, insulin resistance, and arrhythmic risk.
Main Results:
- Trans-fatty acids (TFA) impact multiple non-lipid cardiovascular risk factors.
- Evidence supports TFA's role in promoting systemic inflammation and endothelial dysfunction.
- TFA intake is associated with increased visceral adiposity, insulin resistance, and arrhythmic risk.
Conclusions:
- The non-lipid effects of trans-fatty acids (TFA) provide a comprehensive explanation for their strong association with coronary heart disease (CHD) risk.
- These adverse non-lipid pathways also elucidate TFA's contribution to other non-CHD health issues.
- Dietary guidance should consider the multifaceted negative health impacts of industrially produced trans-fatty acids.
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Structure of Lipids
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management